Submit Search
Upload
Carla e turma
•
Download as PPT, PDF
•
0 likes
•
182 views
2
28011985
Follow
Report
Share
Report
Share
1 of 4
Download now
Recommended
Time-based bioactivity analysis
Time-based bioactivity analysis
Matthew Clark
Resume2016
Resume2016
Tinopiwa Miller
Bioactivity Predictive ModelingMay2016
Bioactivity Predictive ModelingMay2016
Matthew Clark
Learn Reaxys search methods and best practices around database search querying. With access to over 500 million published experimental facts, chemists can efficiently support their early drug discovery research, material selection and synthesis planning. - How to use the main features in Reaxys - The ways in which search results focus on relevance versus comprehensiveness - How information is indexed and organized according to the principles of chemistry taxonomy More about Reaxys. Reaxys is a unique web-based chemistry workflow solution. It supports research and fuels discovery by integrating searches for reaction and substance data with synthesis planning and chemical sourcing. Check out www.reaxys.com/info for more information.
Intro reaxys
Intro reaxys
Ann-Marie Roche
Learn how large-scale normalized data empowers the critical early phases of drug discovery. To address the core concerns about data quality, comprehensiveness and comparability, the Reaxys product team has developed a completely new repository for bioactivity information. Reaxys Medicinal Chemistry stands as a unique source for normalized data in vitro efficacy, in vivo animal models, compound metabolism, pharmacokinetics and toxicity. This presentation takes a look at how this approach to data supports critical early discovery methods such as in silico screening and target profiling.
Data drivenapproach to medicinalchemistry
Data drivenapproach to medicinalchemistry
Ann-Marie Roche
Dr. Olivier Barberan introduced us to the main features and benefits of using our medicinal chemistry database.
Reaxys Medicinal Chemistry: An introduction - webinar September 18 2013
Reaxys Medicinal Chemistry: An introduction - webinar September 18 2013
Ann-Marie Roche
2014.apr.rx
2014.apr.rx
Pei Shan Leow
Slides from webinar held on Oct. 23, 2014
Reaxys medicinal chemistry oct2014
Reaxys medicinal chemistry oct2014
Reaxys
Recommended
Time-based bioactivity analysis
Time-based bioactivity analysis
Matthew Clark
Resume2016
Resume2016
Tinopiwa Miller
Bioactivity Predictive ModelingMay2016
Bioactivity Predictive ModelingMay2016
Matthew Clark
Learn Reaxys search methods and best practices around database search querying. With access to over 500 million published experimental facts, chemists can efficiently support their early drug discovery research, material selection and synthesis planning. - How to use the main features in Reaxys - The ways in which search results focus on relevance versus comprehensiveness - How information is indexed and organized according to the principles of chemistry taxonomy More about Reaxys. Reaxys is a unique web-based chemistry workflow solution. It supports research and fuels discovery by integrating searches for reaction and substance data with synthesis planning and chemical sourcing. Check out www.reaxys.com/info for more information.
Intro reaxys
Intro reaxys
Ann-Marie Roche
Learn how large-scale normalized data empowers the critical early phases of drug discovery. To address the core concerns about data quality, comprehensiveness and comparability, the Reaxys product team has developed a completely new repository for bioactivity information. Reaxys Medicinal Chemistry stands as a unique source for normalized data in vitro efficacy, in vivo animal models, compound metabolism, pharmacokinetics and toxicity. This presentation takes a look at how this approach to data supports critical early discovery methods such as in silico screening and target profiling.
Data drivenapproach to medicinalchemistry
Data drivenapproach to medicinalchemistry
Ann-Marie Roche
Dr. Olivier Barberan introduced us to the main features and benefits of using our medicinal chemistry database.
Reaxys Medicinal Chemistry: An introduction - webinar September 18 2013
Reaxys Medicinal Chemistry: An introduction - webinar September 18 2013
Ann-Marie Roche
2014.apr.rx
2014.apr.rx
Pei Shan Leow
Slides from webinar held on Oct. 23, 2014
Reaxys medicinal chemistry oct2014
Reaxys medicinal chemistry oct2014
Reaxys
Learn how Reaxys handles data from multiple sources
Reaxys rmc unified platform_ webinar_
Reaxys rmc unified platform_ webinar_
Ann-Marie Roche
Slides for "Reaxys Medicinal Chemistry And Drug Repurposing" webinar held Nov. 20, 2014
Reaxys Medicinal Chemistry Nov20 2014
Reaxys Medicinal Chemistry Nov20 2014
Reaxys
Drug discovery expert, Jim Rinker, will discuss the process for exploring drug targets for schizophrenia using the tools in Elsevier's R&D portfolio. This approach features a specific workflow between Reaxys Medicinal Chemistry and Pathway Studio. Beginning with mapping known schizophrenia drugs to regulators, Mr. Rinker will walk through the keys steps in finding the proper drug used to improve cognitive function. This step-by-step method of research and data extraction will demonstrate how using these platforms can help identify side effects, build a consensus model, properly profile drugs and effectively map cognition.
Pathway studio reaxys medicinal chemistry schizophrenia presentation 063015
Pathway studio reaxys medicinal chemistry schizophrenia presentation 063015
Ann-Marie Roche
Drug Analytics in Embase
Drug analytics based on triple linking v1.0
Drug analytics based on triple linking v1.0
Ann-Marie Roche
The talk describes the science and results of a consortium of multiple pharmaceutical companies extracting medicinal chemistry knowledge from research data and the application to real drug design projects. A new technique for automating pharmacophore / toxophore finding from public data is disclosed.
MedChemica - Extracting and exploiting medicinal chemistry ADMET knowledge au...
MedChemica - Extracting and exploiting medicinal chemistry ADMET knowledge au...
Al Dossetter
Introduction to the Reaxys Medicinal Chemistry Database. These slides were used for a webinar presented on July 22, 2014.
Reaxys Medicinal Chemistry 2014
Reaxys Medicinal Chemistry 2014
Reaxys
The pressures of pharmaceutical research and development demand increasing efficiency from scientists. High-quality decisions must be made faster and encompass all available information. At the same time there is a growing desire to better utilize the multi-billion dollar research investment recorded in laboratory notebooks and bioassay databases. Key values for data integration in a data exploration environment include gathering data from disparate E-notebooks and bioassay databases into a single searchable “virtual” system and increased discoverability by accessing data through a system designed for exploration. Key benefits are better chemistry decisions through easier access to broader data and reduced time for preparing patent filings. The ability to interlink in-house and reported assay data with in-house and published chemistry provides a data-rich environment for developing insights and predictive models. We will discuss our experience with integrating information from journals, patents, bio-assay databases, and E-lab notebooks to address these needs.
ICIC 2014 Increasing the efficiency of pharmaceutical research through data i...
ICIC 2014 Increasing the efficiency of pharmaceutical research through data i...
Dr. Haxel Consult
These are the slides for the Reaxys Medicinal Chemistry webinar that was held on October 16, 2013.
Reaxys Medicinal Chemistry
Reaxys Medicinal Chemistry
Reaxys
Medical Device Reporting
Medical device reporting 27 sep2016
Medical device reporting 27 sep2016
Ann-Marie Roche
lecture 1 information systems and business strategy
lecture 1 information systems and business strategy
Norazila Mat
Corrective and Preventive Actions - a guide for FDA regulations and best practices
CAPA Training Presentation
CAPA Training Presentation
Nancy Watts
More Related Content
Viewers also liked
Learn how Reaxys handles data from multiple sources
Reaxys rmc unified platform_ webinar_
Reaxys rmc unified platform_ webinar_
Ann-Marie Roche
Slides for "Reaxys Medicinal Chemistry And Drug Repurposing" webinar held Nov. 20, 2014
Reaxys Medicinal Chemistry Nov20 2014
Reaxys Medicinal Chemistry Nov20 2014
Reaxys
Drug discovery expert, Jim Rinker, will discuss the process for exploring drug targets for schizophrenia using the tools in Elsevier's R&D portfolio. This approach features a specific workflow between Reaxys Medicinal Chemistry and Pathway Studio. Beginning with mapping known schizophrenia drugs to regulators, Mr. Rinker will walk through the keys steps in finding the proper drug used to improve cognitive function. This step-by-step method of research and data extraction will demonstrate how using these platforms can help identify side effects, build a consensus model, properly profile drugs and effectively map cognition.
Pathway studio reaxys medicinal chemistry schizophrenia presentation 063015
Pathway studio reaxys medicinal chemistry schizophrenia presentation 063015
Ann-Marie Roche
Drug Analytics in Embase
Drug analytics based on triple linking v1.0
Drug analytics based on triple linking v1.0
Ann-Marie Roche
The talk describes the science and results of a consortium of multiple pharmaceutical companies extracting medicinal chemistry knowledge from research data and the application to real drug design projects. A new technique for automating pharmacophore / toxophore finding from public data is disclosed.
MedChemica - Extracting and exploiting medicinal chemistry ADMET knowledge au...
MedChemica - Extracting and exploiting medicinal chemistry ADMET knowledge au...
Al Dossetter
Introduction to the Reaxys Medicinal Chemistry Database. These slides were used for a webinar presented on July 22, 2014.
Reaxys Medicinal Chemistry 2014
Reaxys Medicinal Chemistry 2014
Reaxys
The pressures of pharmaceutical research and development demand increasing efficiency from scientists. High-quality decisions must be made faster and encompass all available information. At the same time there is a growing desire to better utilize the multi-billion dollar research investment recorded in laboratory notebooks and bioassay databases. Key values for data integration in a data exploration environment include gathering data from disparate E-notebooks and bioassay databases into a single searchable “virtual” system and increased discoverability by accessing data through a system designed for exploration. Key benefits are better chemistry decisions through easier access to broader data and reduced time for preparing patent filings. The ability to interlink in-house and reported assay data with in-house and published chemistry provides a data-rich environment for developing insights and predictive models. We will discuss our experience with integrating information from journals, patents, bio-assay databases, and E-lab notebooks to address these needs.
ICIC 2014 Increasing the efficiency of pharmaceutical research through data i...
ICIC 2014 Increasing the efficiency of pharmaceutical research through data i...
Dr. Haxel Consult
These are the slides for the Reaxys Medicinal Chemistry webinar that was held on October 16, 2013.
Reaxys Medicinal Chemistry
Reaxys Medicinal Chemistry
Reaxys
Medical Device Reporting
Medical device reporting 27 sep2016
Medical device reporting 27 sep2016
Ann-Marie Roche
lecture 1 information systems and business strategy
lecture 1 information systems and business strategy
Norazila Mat
Corrective and Preventive Actions - a guide for FDA regulations and best practices
CAPA Training Presentation
CAPA Training Presentation
Nancy Watts
Viewers also liked
(11)
Reaxys rmc unified platform_ webinar_
Reaxys rmc unified platform_ webinar_
Reaxys Medicinal Chemistry Nov20 2014
Reaxys Medicinal Chemistry Nov20 2014
Pathway studio reaxys medicinal chemistry schizophrenia presentation 063015
Pathway studio reaxys medicinal chemistry schizophrenia presentation 063015
Drug analytics based on triple linking v1.0
Drug analytics based on triple linking v1.0
MedChemica - Extracting and exploiting medicinal chemistry ADMET knowledge au...
MedChemica - Extracting and exploiting medicinal chemistry ADMET knowledge au...
Reaxys Medicinal Chemistry 2014
Reaxys Medicinal Chemistry 2014
ICIC 2014 Increasing the efficiency of pharmaceutical research through data i...
ICIC 2014 Increasing the efficiency of pharmaceutical research through data i...
Reaxys Medicinal Chemistry
Reaxys Medicinal Chemistry
Medical device reporting 27 sep2016
Medical device reporting 27 sep2016
lecture 1 information systems and business strategy
lecture 1 information systems and business strategy
CAPA Training Presentation
CAPA Training Presentation
Editor's Notes
{}
Download now